Telephone-Delivered Interventions for Smoking Cessation

Smoking Clinical Trial

— TALK  

Official title:

Telephone-Delivered Interventions for Smoking Cessation

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02421991
• Other study ID #: 8298
• Secondary ID: NCI-2018-02635RG
• Status: Completed
• Phase: N/A
• Start date: November 2, 2015
• Est. completion date: December 31, 2019

Study information

• Verified date: November 2019
• Source: Fred Hutchinson Cancer Research Center
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to demonstrate that Acceptance and Commitment Therapy's (ACT) implementation outcomes are at least as good as those of traditional cognitive behavioral therapy (CBT).

Recruitment information / eligibility

• Status: Completed
• Enrollment: 1275
• Est. completion date: December 31, 2019
• Est. primary completion date: August 8, 2018
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

1. ages 18 and older

2. smokes at least ten cigarettes per day (to be eligible for NRT) and has done so for at least the past 12 months

3. wants to quit smoking in the next 30 days

4. if concurrently using any other nicotine or tobacco products wants to quit using them within the next 30 days

5. willing to be randomly assigned to either group

6. willing and able to speak and read in English

7. willing and medically eligible to use NRT

8. resides in the U.S., and expects to continue for at least 12 months

9. not participating in other smoking cessation interventions (including our own intervention trials)

10. has regular access to a telephone.

Exclusion Criteria:

The exclusion criteria are opposite of the inclusion criteria listed above.

In addition we will exclude:

1. anyone who is pregnant or breast feeding

2. has had a heart attack in the past 30 days

3. has unstable angina

4. has evidence of arrhythmia in the past 6 months

5. has a history of severe skin reaction to adhesive patches.

Related Conditions & MeSH terms

• Smoking

Intervention

Behavioral:
• Telephone Delivered Intervention

Locations

Country	Name	City	State
United States	Fred Hutchinson Cancer Research Center	Seattle	Washington

Sponsors (4)

Lead Sponsor	Collaborator
Fred Hutchinson Cancer Research Center	Alere Wellbeing, National Cancer Institute (NCI), National Institute on Drug Abuse (NIDA)

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	30 day point prevalence abstinence	No smoking in the past 30 days, as reported at 12 month post treatment	12 months